Shares of AbbVie Inc. ABBV rose 1.79% to $200.88 Thursday, on what proved to be an all-around poor trading session for the ...
The celebrity doctor said he would divest from his interests in many drug, medical and insurance companies, worth millions of ...
AbbVie has launched its Produodopa therapy for Parkinson’s disease onto the market in the EU, becoming the first and only 24-hour levodopa-based subcutaneous infusion therapy for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback